UNSPSC 51333405: Fenaperone

This classification denotes an anxiolytic with the molecular formula C21H29FN2O3, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier V6W7F1R86P, chemically known as 4-(3-(p-fluorobenzoyl)-propyl)-1-piperazinecarboxylic acid, cyclohexyl ester. but generally known as fenaperone, which bears US NIH Compound Identifier 198061. European Medicines Agency schedules Fenaperone in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB07540MIG.

UNSPSC 51333405 Fenaperone, a Commodity code, does not align with the recent state and local procurement activity tagged under it. The single opportunity on record—Seminole County, Florida's IFB for Naloxone and Safe Drug Deactivation Systems—involves opioid-reversal medications and harm-reduction equipment, not Fenaperone, a pharmaceutical compound outside the scope of standard state and local health procurement. This mismatch suggests either a data classification error or that the code sees minimal relevant activity in the state and local market.

Seminole County's July 2026 solicitation (IFB60459723LAS, response due July 26, 2023) sought 1,900 units of Naloxone and 800 Safe Drug Deactivation Systems annually on a two-year contract with one-year renewal option, with quarterly deliveries to the Seminole County Community Health Building in Sanford, Florida. The procurement required electronic bid submission through the county's e-Procurement Portal, included E-Verify and drug-free workplace compliance, and carried potential FEMA funding with associated federal environmental compliance obligations. No explicit set-aside or disadvantaged-enterprise designations were noted. Without additional opportunities in the code's record showing Fenaperone or related products actually being purchased by state and local governments, the code presents little actionable procurement signal for business development purposes.